Erasmus University Rotterdam (EUR) is a research university with a pronounced social orientation in its education and research. Academics and students at our institution endeavour to solve global social challenges, drawing inspiration from the metropolis Rotterdam. EUR employs in 2015 more than 2,700 staff members (1304 men and 1430 women) and has an annual turnover of around 550 million Euros. In 2015 there were 26,212 students studying at Erasmus; 7,337 students graduated and 374 completed their PhD thesis.
ESHPM has in total 150 staff members and more than 950 students. All researchers and staffmembers of the Erasmus School of Health Policy & Management (ESHPM) adhere to the principles of good academic research as described in the VSNU guidelines for academic practice (Netherlands Code of Conduct for Academic Practice) and in Erasmus University Rotterdam Integrity Code.
The Erasmus School of Health Policy & Management (ESHPM) is a Dutch school with a strong international reputation in health services research in general, and in health economics (HE) research and health technology assessment (HTA) in particular. It is a multidisciplinary school with 3 major research themes: competition and regulation in health care, quality and efficiency in health care and management and organization of health care delivery.
The research programmes of the Erasmus School of Health Policy & Management (ESHPM) are characterized by their multidisciplinarity. Scientists from various disciplines (e.g. health economics, health law, science of public administration and medical sociology) work together on the domain of health care. The Health Economics group is involved in various research programs, most of which are dealing with the area of "Health Technology Assessment". In HE and HTA research and education, it is one of the leading organisation at international level. It has built considerable experience with the management and coordination of EU-funded projects, having coordinated 4 Concerted Actions (CA), one Research and Technological Development (RTD) project and 2 Seventh Framework Programme for Research and Technological Development (FP-7) projects over the past years. The organisation participated as a partner in 7 additional FP-7 projects.
Professor JL (Hans) SEVERENS PhD (M) is health scientist by training and Professor of Evaluation research of Erasmus School of Health Policy & Management (ESHPM).
He will be Work Package leader of WP#4 on Cost-effectiveness. He has over 25 years of experience in both teaching and research in the field of health technology assessment (HTA) and cost-effectiveness studies, resulting in over 250 high-level publications in economic as well as medical journals. He has been project leader of numerous (inter-) national projects, for instance being co-leader of an international team of researcher contracted by the National Institute of Health and Clinical Excellence, UK. His experience regards modeling studies in several disease areas including a number of chronic diseases such as heart failure, rheumatoid arthritis and glaucoma. His other related activities are numerous varying from having been co-editor for over 10 years of the high impact journal Value in Health, former board member of ISPOR, former member of the Reimbursement Committee of the Health Care Insurance Board, and currently being Vice-president of the National Health Council.